Janssen Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
Plaintiff: Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Institutional LLC
Case Number: 1:2019cv01488
Filed: August 9, 2019
Court: US District Court for the District of Delaware
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35:271
Jury Demanded By: None
Docket Report

This docket was last retrieved on August 9, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
August 9, 2019 Summons Issued with Magistrate Consent Notice attached as to Mylan Institutional LLC on 8/9/2019; Mylan Laboratories Limited on 8/9/2019; Mylan Pharmaceuticals Inc. on 8/9/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam)
August 9, 2019 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. (sam)
August 9, 2019 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,439,906 B2. (sam)
August 9, 2019 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 2, 2019. Date of Expiration of Patent: January 26, 2031.Thirty Month Stay Deadline: 1/2/2022. (sam)
August 9, 2019 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam)
August 9, 2019 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Institutional LLC, Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2705242.) - filed by Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(sam)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Janssen Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Janssen Pharmaceutica NV
Represented By: Brian P. Egan
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Janssen Pharmaceuticals, Inc.
Represented By: Brian P. Egan
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Pharmaceuticals Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Laboratories Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Institutional LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?